
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Minocycline prevents photoreceptor degeneration in Retinitis pigmentosa through modulating mitochondrial homeostasis
Yuxun Shi, Yuxi Chen, Yuan Pan, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112703-112703
Closed Access | Times Cited: 3
Yuxun Shi, Yuxi Chen, Yuan Pan, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112703-112703
Closed Access | Times Cited: 3
Showing 3 citing articles:
Inhibiting HMGB1/AGER/NF-κB pathway prevents pro-inflammatory microglia polarization and protect photoreceptors in retinitis pigmentosa
Chaojun Hu, Tao Cui, Zihang Xu, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114192-114192
Open Access | Times Cited: 1
Chaojun Hu, Tao Cui, Zihang Xu, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114192-114192
Open Access | Times Cited: 1
ZLN005, a PGC-1α agonist, delays photoreceptor degeneration by enhancing mitochondrial biogenesis in a murine model of retinitis pigmentosa
Chaojun Hu, Chengda Ren, Yan Wu, et al.
Neuropharmacology (2025) Vol. 269, pp. 110361-110361
Open Access
Chaojun Hu, Chengda Ren, Yan Wu, et al.
Neuropharmacology (2025) Vol. 269, pp. 110361-110361
Open Access
Efficacy and safety of minocycline in retinitis pigmentosa: a prospective, open-label, single-arm trial
Yuxi Chen, Yuan Pan, Yanyan Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access
Yuxi Chen, Yuan Pan, Yanyan Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access